MAPT and Alzheimer disease: Blood-brain barrier dysfunction is associated with early cognitive decline in vascular cognitive impairment (Li et al., 2021) and Alzheimer's disease patients (Bowman et al., 2018) even in the absence of amyloid-β and tau changes (Nation et al., 2019).